Overview


According to FutureWise analysis the market for nebulizer in 2023 is US$ 1.14 billion, and is expected to reach US$ 1.83 billion by 2031 at a CAGR of 6.12%.

The medical equipment known as a nebulizer is used to produce a mist out of liquid medicine that can be inhaled into the lungs. It is often used to deliver medication to treat several respiratory conditions, such as asthma, COPD, and cystic fibrosis. A nebulizer works by using ultrasonic vibrations or compressed air to break up the liquid medication into small droplets that can be easily inhaled into the lungs. The nebulizer machine is typically connected to a mouthpiece or mask that the patient uses to inhale the mist of medication. The patient usually sits or lies down during the treatment, and the nebulizer machine is turned on to deliver the medication.

The duration of treatment depends on the medication being administered and typically lasts between 5 and 20 minutes. The frequency of nebulizer treatments can vary depending on the patient's condition and the medication being administered. Some patients may need to use their nebulizer several times a day, while others may only need to use it occasionally. It is crucial to adhere to the guidelines provided by the healthcare provider when using a nebulizer, as well as to clean the nebulizer after each use to prevent contamination and ensure proper functioning.

FutureWise Market Research has published a report that provides an insightful analysis of Nebulizer Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Nebulizer Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Beurer GmbH
  • GF Health Products Inc.
  • PARI GmbH
  • Allied Healthcare Products Inc.
  • Aerogen Ltd.
  • Briggs Healthcare
  • OMRON Corporation
  • Rossmax Swiss GmbH
  • Vectura Group plc.
  • Becton, Dickinson and Company
  • General Electric Company
  • Agilent Technologies Inc.
  • Medline Industries Inc.
  • Koninklijke Philips N.V.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Nebulizer Market:

In July 2022, Ziccum inked a contract with TEKCELEO, a creative mechatronic company with extensive nebulizer experience, to develop its latest nebulizer.

In recent years, the nebulizer market has grown significantly, propelled by a number of crucial factors. One of the primary drivers is the rising prevalence of respiratory illnesses such as cystic fibrosis, COPD, and asthma. According to the World Health Organization, asthma affects around 339 million people globally, while COPD affects around 251 million people. These figures are expected to rise in the coming years, driving demand for nebulizers. Another factor driving growth in the nebulizer market is the increasing adoption of home healthcare services. With the rise of chronic diseases, patients are increasingly opting for home-based treatment options, including the use of nebulizers. Home healthcare services are particularly popular among the elderly and patients with mobility issues, who may find it challenging to visit hospitals or clinics for treatment. Moreover, technological advancements in nebulizers have also contributed to the growth of the market. The development of portable nebulizers has made it easier for patients to receive treatment anytime and anywhere without requiring a power supply or compressor. In addition, the development of vibrating mesh nebulizers, which use a vibrating mesh to generate a fine mist of medication, has also increased the efficiency and effectiveness of nebulizers.

Despite the growth prospects, there are also several challenges faced by the nebulizer market. One of the significant challenges is the high cost of nebulizers, which can be a barrier to access for some patients.

By Product Type

  • Pneumatic
    •  Breath-actuated
    •  Vented
  • Ultrasonic
  • Mesh
    •  Vibrating mesh
    •  Static mesh

By Portability

  • Portable
  • Stand-Alone

By Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Others

By End User

  • Hospitals and Ambulatory Surgical Centers (ASCs)
  • Emergency Centers
  • Clinics
  •  Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The North American nebulizer market is likely to expand as a result of ongoing technological advancements in the field of nebulizers. As the population in the region leads a fast-paced lifestyle, patients with asthma and other airway illnesses are looking for more portable nebulizer equipment that can be rapidly used in an emergency. The North American region's major market is the United States. The prevalence of respiratory disorders such as TB, COPD, and sleep apnea is rising in the United States, driving up demand for nebulizers. Furthermore, various mergers, acquisitions, collaborations, and product launches by market participants have a favourable impact on overall market growth. As a result of these factors, the nebulizer market in North America is predicted to increase. Additionally, based on application; COPD segment held the largest market share in 2022

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Nebulizer Market By Product Type, By Portability, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Nebulizer Market Variables, Trends and Scope
    •      1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Nebulizer Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Nebulizer Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Nebulizer Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pneumatic
         1.1. Breath-actuated
         1.2. Vented
        2. Ultrasonic
        3. Mesh
         3.1. Vibrating mesh
         3.2. Static mesh

  • 8.   Nebulizer Market, By Portability Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Portable
        2. Stand-Alone

  • 9.   Nebulizer Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Asthma
        2. Chronic Obstructive Pulmonary Disease (COPD)
        3. Cystic Fibrosis
        4. Others

  • 10.   Nebulizer Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and Ambulatory Surgical Centers (ASCs)
        2. Emergency Centers
        3. Clinics
        4. Others

  • 11.   North America Nebulizer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Nebulizer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Nebulizer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Nebulizer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Beurer GmbH
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. GF Health Products Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. PARI GmbH
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Allied Healthcare Products Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Aerogen Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Briggs Healthcare
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. OMRON Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Rossmax Swiss GmbH
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Vectura Group plc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Becton, Dickinson and Company
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. General Electric Company
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Agilent Technologies Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Medline Industries Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Koninklijke Philips N.V.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients